News and Events

Deep Learning Enables Dual Screening for Cancer and Cardiovascular Disease
Deep Learning Enables Dual Screening for Cancer and Cardiovascular Disease

Heart disease and cancer are the leading causes of death in the United States, and it’s increasingly understood that they share common risk factors, including tobacco use, diet, blood pressure, and obesity. Thus, a diagnostic tool that could screen for cardiovascular disease while a patient is already being screened for cancer has the potential to expedite a diagnosis, accelerate treatment, and improve patient outcomes. 

Polymerized Estrogen Provides Neuroprotection in Preclinical Testing
Polymerized Estrogen Provides Neuroprotection in Preclinical Testing

A novel form of polymerized estrogen developed at Rensselaer Polytechnic Institute can provide neuroprotection when implanted at the site of a spinal cord injury — preventing further damage. This promising result, found in a preclinical model, was recently published in ACS Chemical Neuroscience, and it lays the groundwork for further advancement of this new biomaterial.  

Back to top